Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01535911 : Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
PhaseN/A
AgesMin: 18 Years Max: 90 Years
Eligibility
- Inclusion Criteria:

- Adult subjects over age 18 with biopsy proven GBM diagnosis

- Measurable disease after standard therapies

- Eastern Cancer Oncology Group performance status < or =2; and

- Life expectancy >3 months.

Exclusion Criteria:

- Diagnosis of diabetes mellitus that is being treated by medication

- Concomitant use of glucocorticosteroids

- Cholecystectomy within 1 year prior to study entry

- Inability to adhere to or tolerate dietary protocol

- Active malignancy other than primary brain tumor requiring therapy

- Participation in an investigational study within 2 weeks prior to study entry; Major
co-morbidities such as liver, kidney or heart failure that in the judgment of the
investigators would disqualify the subject from the trial

- Pregnancy

- Inability to give informed consent
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01535911      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740